{{Rsnum
|rsid=249954
|Gene=PALB2
|Chromosome=16
|position=23629146
|Orientation=minus
|GMAF=0.3338
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PALB2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.0 | 29.5 | 3.6
| HCB | 40.0 | 44.4 | 15.6
| JPT | 38.0 | 51.9 | 10.2
| YRI | 27.1 | 52.1 | 20.8
| ASW | 39.3 | 48.2 | 12.5
| CHB | 40.0 | 44.4 | 15.6
| CHD | 36.7 | 49.5 | 13.8
| GIH | 54.5 | 35.4 | 10.1
| LWK | 27.8 | 46.3 | 25.9
| MEX | 54.4 | 38.6 | 7.0
| MKK | 17.4 | 49.0 | 33.5
| TSI | 56.0 | 41.0 | 3.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19921424
|Title=Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population
}}

{{ClinVar
|rsid=249954
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=23640467
|CHROM=16
|GMAF=0.3352
|dbSNPBuildID=79
|SSR=0
|SAO=1
|VP=0x05016808000117051f110101
|GENEINFO=PALB2:79728
|GENE_NAME=PALB2
|GENE_ID=79728
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.23640467G>A
|CLNORIGIN=1
|CLNSIG=2
|CLNCUI=114480
|CLNDBN=Familial cancer of breast
|Tags=RV;PM;PMC;SLO;INT;VLD;G5A;G5;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;PH3;LSD;OM
|CAF=0.6662; 0.3338
|CLNDSDB=OMIM
|CLNDSDBID=114480
|COMMON=1
|Disease=Familial cancer of breast
}}

{{PMID Auto
|PMID=18794107
|Title=Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
}}

{{PMID Auto
|PMID=20122277
|Title=A novel germline PALB2 deletion in Polish breast and ovarian cancer patients.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23453885
  |Trait=Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
  |Title=Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
  |RiskAllele=A
  |Pval=2E-6
  |OR=1.07
  |ORtxt=[1.04-1.10]
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}